These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6146230)

  • 21. Controlled clinical evaluations of celiprolol: an overview.
    Neiss ES
    Br J Clin Pract Suppl; 1985 Jun; 40():17-9. PubMed ID: 2864057
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
    Brandstetter G; Hoffmann H
    Wien Klin Wochenschr; 1984 Sep; 96(18):696-9. PubMed ID: 6240831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A symposium: Hypertension into the nineties. September 6, 1986, Heidelberg, FRG.
    Am J Cardiol; 1988 Feb; 61(5):1C-59C. PubMed ID: 2893530
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute influence of beta-adrenergic antagonists on left ventricular diastolic function: contrasting results after administration of celiprolol and metoprolol.
    Modersohn D; Franz N; Heublein B; Panzner B; Walde T; Bruch L
    J Hum Hypertens; 1994 Feb; 8(2):127-32. PubMed ID: 7911530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of atenolol in moderate-to-mild essential hypertension and in ischemic cardiopathy. Evaluation with the bicycle ergometer].
    Mellini M; Robutti A; Mattiauda C; Cavazzana G; Roych C; Sanfelici D; Baccino M; Reforzo F
    Clin Ter; 1983 Mar; 104(5):391-4. PubMed ID: 6851445
    [No Abstract]   [Full Text] [Related]  

  • 26. [The differential treatment of patients with neurocirculatory dystonia depending on the type of hemodynamic disorders].
    Tatarintsev AN; Dvorkin AI; Semchenko VM
    Ter Arkh; 1993; 65(11):72-4. PubMed ID: 8108807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of propranolol and atenolol on peripheral tissue blood flow and effective plasma flow through the kidneys].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1981 Jun; 36(22):797-9. PubMed ID: 7279762
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
    Ostapiuk FE; Khvoĭnitskiĭ VA
    Sov Med; 1984; (5):87-9. PubMed ID: 6147019
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical cardiac electrophysiologic study of celiprolol.
    Estes NA; Lin SK; Caruso FS; Solomon TA
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S116-8. PubMed ID: 2427839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Suloctidil (sulocton) in the treatment of atherosclerotic neurasthenic syndromes].
    Prusiński A; Kotwica S; Niewodniczy A; Split W
    Wiad Lek; 1982 May; 35(3-4):201-5. PubMed ID: 6287740
    [No Abstract]   [Full Text] [Related]  

  • 31. [Coronary disease and antihypertensive treatment with beta blockers in older patients].
    Wikstrand J
    Cardiologia; 1984; 29(1-2):129-44. PubMed ID: 6152540
    [No Abstract]   [Full Text] [Related]  

  • 32. [Role of calcium antagonists in therapy of coronary heart disease. Experimental report on the calcium antagonist fendiline, and the beta receptor blockader metoprolol].
    Ardjah H
    Med Welt; 1980 Sep; 31(37):1326-30. PubMed ID: 7432128
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta blockers: the extended family.
    Hager WD; Messineo FC; Katz AM
    Adv Intern Med; 1984; 30():201-29. PubMed ID: 6152107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of vegetovascular dystonia with beta-blockaders and tranquilizers].
    Zubarev IuG; Kulakov SA
    Sov Med; 1985; (3):83-5. PubMed ID: 2862710
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of meteorologic pathological reactions in patients with ischemic heart disease and neurocirculatory asthenia].
    Revutskiĭ EL; Nikberg II; Novikova TG; Fedorishko SS
    Vrach Delo; 1988 Feb; (2):7-10. PubMed ID: 3381526
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sympathomimetics or vasotonic sympatholytics in the treatment of the orthostatic syndrome?].
    Husmann F
    Med Klin; 1966 Mar; 61(10):379-82. PubMed ID: 5991680
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of indometacin and acetylsalicylic acid on the therapeutic effectiveness of talinolol in patients with essential hypertension.
    Sziegoleit W; Ehrhardt A; Haase P; Beitz J; Block HU; Fahr A
    Biomed Biochim Acta; 1984; 43(8-9):S463-6. PubMed ID: 6151396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blockers in hypertensive and coronary heart disease.
    Goldstein S
    Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Celiprolol improves glucose metabolism in essential hypertension].
    Oksa A; Fedelesová V; Spustová V; Dzúrik R
    Vnitr Lek; 1998 Feb; 44(2):63-7. PubMed ID: 9820078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.